DJIA 18,026.29 -99.83 -0.55%
NASDAQ 5,078.32 -19.66 -0.39%
S&P 500 2,112.94 -7.85 -0.37%
market minute promo

Johnson & Johnson (NYSE: JNJ)

100.84 -0.31 (-0.31%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $100.80 -0.35%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.55
Previous Close $101.15
Daily Range $100.61 - $101.62
52-Week Range $95.10 - $109.49
Market Cap $279.6B
P/E Ratio 18.09
Dividend (Yield) $3.00 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,095,841
Average Daily Volume 7,327,055
Current FY EPS $6.14




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

Gilead's Sustainable Competitive Advantage

Gilead Sciences' long-term growth is being doubted by the Street because of the uncertainty surrounding the hep C market going forward. The biotech's top notch CEO John Martin, however, should be reason enough for investors to believe that company's best days lie ahead. Here's why.

Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 01, 2015

1 Positive, 1 Negative For Johnson & Johnson Stock

3 Keys Why Retired Investors Should Put Maximum Focus And Weight On Dividends

Which Dividend ETFs Provide Steadiest Income?

Johnson & Johnson: Quiz Of The Day

James Barrow increases his position in Johnson and Johnson

Insiders Buy The Dip In DepoMed

Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog

Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog

PRIMECAP Sells Portions of Its Top Two Stakes

See More JNJ News...

JNJ's Top Competitors

JNJ $100.84 (-0.31%)
Current stock: JNJ
PFE $34.80 (1.05%)
Current stock: PFE
MRK $59.79 (0.15%)
Current stock: MRK
BSX $18.46 (1.04%)
Current stock: BSX